<DOC>
	<DOCNO>NCT00137007</DOCNO>
	<brief_summary>The intravenous ( IV ) regimen contain azithromycin ( Zithromax ) plus ampicillin-sulbactam consistent current guideline treatment CAP . In fact International guideline treatment CAP hospitalise patient suggest use combination b-lactam macrolide . This trial allow investigator evaluate efficacy azithromycin plus ampicillin-sulbactam treatment hospitalized subject community acquire pneumonia . In addition , trial allow investigator evaluate safety toleration combination therapy .</brief_summary>
	<brief_title>Zithromax EV Community-Acquired Pneumonia ( CAP )</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Sulbactam</mesh_term>
	<mesh_term>Sultamicillin</mesh_term>
	<mesh_term>Ampicillin</mesh_term>
	<criteria>Subjects must require hospitalization intravenous therapy . Subjects must Fine pneumonia score &gt; 70 ( Fine Class &gt; II ) . Subjects must medical history clinical radiological finding consistent communityacquired bronchopneumonia lobar pneumonia . The following criterion must meet : new infiltrate ( ) chest Xray ; AND least two CAP sign symptom . Treatment systemic antibiotic 24 hour longer within 72 hour baseline visit , treatment 7 day within 15 day . Specific systemic disease medical condition would interfere evaluation therapeutic response safety study drug , include : Known acquire immunodeficiency syndrome ( AIDS ) suspect Pneumocystis carinii pneumonia ; Neutropenia ; Cavitary lung disease chest Xray ; Primary lung cancer malignancy metastatic lung ; Aspiration pneumonia ; Empyema ; Known suspect tuberculosis ; Neoplastic disease ; Cystic fibrosis ; A history form epilepsy seizure ; DDM ; Bronchiectasis , bronchial obstruction history postobstructive pneumonia ( exclude patient chronic obstructive pulmonary disease ) ; Significant gastrointestinal condition may affect study drug absorption ; Significant cardiovascular disorder . Immunosuppressive therapy , define chronic treatment know immunosuppressant medication Impaired hepatic function , show , limited , AST , ( SGOT ) , ALT ( SGPT ) great three time laboratory upper limit normal , total bilirubin great two time upper limit normal . Subjects already hospitalize reside longtermcare facility great 14 day onset symptom .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>